Cargando…
Factors predicting staging and treatment initiation for patients with chronic hepatitis C infection: insurance a key predictor
BACKGROUND: Chronic hepatitis C (HCV) infection affects over 2.4 million Americans and accounts for 18 000 deaths per year. Treatment initiation in this population continues to be low even after introduction of highly effective and shorter duration direct-acting antivirals. This study assesses facto...
Autores principales: | , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8904194/ https://www.ncbi.nlm.nih.gov/pubmed/33539524 http://dx.doi.org/10.1093/pubmed/fdaa276 |
_version_ | 1784664904139014144 |
---|---|
author | Lin, Janet Mauntel-Medici, Cammeo Maheswaran, Anjana Bairavi Baghikar, Sara Pugach, Oksana Stein, Ellen M Martin, Michelle T Nguyen, Hai |
author_facet | Lin, Janet Mauntel-Medici, Cammeo Maheswaran, Anjana Bairavi Baghikar, Sara Pugach, Oksana Stein, Ellen M Martin, Michelle T Nguyen, Hai |
author_sort | Lin, Janet |
collection | PubMed |
description | BACKGROUND: Chronic hepatitis C (HCV) infection affects over 2.4 million Americans and accounts for 18 000 deaths per year. Treatment initiation in this population continues to be low even after introduction of highly effective and shorter duration direct-acting antivirals. This study assesses factors that influence key milestones in the HCV care continuum. METHODS: Retrospective time-to-event analyses were performed to assess factors influencing liver fibrosis staging and treatment initiation among individuals confirmed with chronic HCV infection at University of Illinois Hospital and Health Sciences System between 1 August 2015 and 24 October 2016 and followed through 28 January 2018. Cox regression models were utilized for multivariable analyses. RESULTS: Individuals tested at the liver clinic (hazard ratio [HR] = 2.03; 95% confidence interval [CI]: 1.19–3.46) and at the federally qualified health center (HR = 3.51; 95% CI: 2.19–5.64) had higher instantaneous probability of being staged compared with individuals tested at the emergency department (ED) or inpatient setting. And probability of treatment initiation increased with advancing liver fibrosis especially for Medicaid beneficiaries (HR = 1.64; 95% CI: 1.35–1.99). CONCLUSIONS: The study demonstrates a need for improving access for patients with early stages of the disease in order to reduce HCV-related morbidity and mortality, especially those tested at nontraditional care locations such as the ED or the inpatient setting. |
format | Online Article Text |
id | pubmed-8904194 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | Oxford University Press |
record_format | MEDLINE/PubMed |
spelling | pubmed-89041942022-03-09 Factors predicting staging and treatment initiation for patients with chronic hepatitis C infection: insurance a key predictor Lin, Janet Mauntel-Medici, Cammeo Maheswaran, Anjana Bairavi Baghikar, Sara Pugach, Oksana Stein, Ellen M Martin, Michelle T Nguyen, Hai J Public Health (Oxf) Original Article BACKGROUND: Chronic hepatitis C (HCV) infection affects over 2.4 million Americans and accounts for 18 000 deaths per year. Treatment initiation in this population continues to be low even after introduction of highly effective and shorter duration direct-acting antivirals. This study assesses factors that influence key milestones in the HCV care continuum. METHODS: Retrospective time-to-event analyses were performed to assess factors influencing liver fibrosis staging and treatment initiation among individuals confirmed with chronic HCV infection at University of Illinois Hospital and Health Sciences System between 1 August 2015 and 24 October 2016 and followed through 28 January 2018. Cox regression models were utilized for multivariable analyses. RESULTS: Individuals tested at the liver clinic (hazard ratio [HR] = 2.03; 95% confidence interval [CI]: 1.19–3.46) and at the federally qualified health center (HR = 3.51; 95% CI: 2.19–5.64) had higher instantaneous probability of being staged compared with individuals tested at the emergency department (ED) or inpatient setting. And probability of treatment initiation increased with advancing liver fibrosis especially for Medicaid beneficiaries (HR = 1.64; 95% CI: 1.35–1.99). CONCLUSIONS: The study demonstrates a need for improving access for patients with early stages of the disease in order to reduce HCV-related morbidity and mortality, especially those tested at nontraditional care locations such as the ED or the inpatient setting. Oxford University Press 2021-02-05 /pmc/articles/PMC8904194/ /pubmed/33539524 http://dx.doi.org/10.1093/pubmed/fdaa276 Text en © The Author(s) 2021. Published by Oxford University Press on behalf of Faculty of Public Health. https://creativecommons.org/licenses/by-nc-nd/4.0/This is an Open Access article distributed under the terms of the Creative Commons Attribution NonCommercial-NoDerivs licence (https://creativecommons.org/licenses/by-nc-nd/4.0/), which permits non-commercial reproduction and distribution of the work, in any medium, provided the original work is not altered or transformed in any way, and that the work properly cited. For commercial re-use, please contact journals.permissions@oup.com |
spellingShingle | Original Article Lin, Janet Mauntel-Medici, Cammeo Maheswaran, Anjana Bairavi Baghikar, Sara Pugach, Oksana Stein, Ellen M Martin, Michelle T Nguyen, Hai Factors predicting staging and treatment initiation for patients with chronic hepatitis C infection: insurance a key predictor |
title | Factors predicting staging and treatment initiation for patients with chronic hepatitis C infection: insurance a key predictor |
title_full | Factors predicting staging and treatment initiation for patients with chronic hepatitis C infection: insurance a key predictor |
title_fullStr | Factors predicting staging and treatment initiation for patients with chronic hepatitis C infection: insurance a key predictor |
title_full_unstemmed | Factors predicting staging and treatment initiation for patients with chronic hepatitis C infection: insurance a key predictor |
title_short | Factors predicting staging and treatment initiation for patients with chronic hepatitis C infection: insurance a key predictor |
title_sort | factors predicting staging and treatment initiation for patients with chronic hepatitis c infection: insurance a key predictor |
topic | Original Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8904194/ https://www.ncbi.nlm.nih.gov/pubmed/33539524 http://dx.doi.org/10.1093/pubmed/fdaa276 |
work_keys_str_mv | AT linjanet factorspredictingstagingandtreatmentinitiationforpatientswithchronichepatitiscinfectioninsuranceakeypredictor AT mauntelmedicicammeo factorspredictingstagingandtreatmentinitiationforpatientswithchronichepatitiscinfectioninsuranceakeypredictor AT maheswarananjanabairavi factorspredictingstagingandtreatmentinitiationforpatientswithchronichepatitiscinfectioninsuranceakeypredictor AT baghikarsara factorspredictingstagingandtreatmentinitiationforpatientswithchronichepatitiscinfectioninsuranceakeypredictor AT pugachoksana factorspredictingstagingandtreatmentinitiationforpatientswithchronichepatitiscinfectioninsuranceakeypredictor AT steinellenm factorspredictingstagingandtreatmentinitiationforpatientswithchronichepatitiscinfectioninsuranceakeypredictor AT martinmichellet factorspredictingstagingandtreatmentinitiationforpatientswithchronichepatitiscinfectioninsuranceakeypredictor AT nguyenhai factorspredictingstagingandtreatmentinitiationforpatientswithchronichepatitiscinfectioninsuranceakeypredictor |